HFMA Comments on Request for Information Regarding Medical Payment Products
HFMA presents its comment letter to CMS on Request for Information Regarding Medical Payment Products
HFMA Comments on Hospital OPPS: Proposed Remedy for the 340B-Acquired Drug Payment Policy for CYs 2018–2022
HFMA presents its comment letter to CMS on the proposed rule, Medicare Program; Hospital Outpatient Prospective Payment System: Remedy for the 340B-Acquired Drug Payment Policy for Calendar Years 2018–2022.
comment_letter
HFMA Offers Recommendations to Senate to Reduce Total Cost of Care while Improving Patient Outcomes
This letter contains HFMA's recommendations to the Senate HELP committee on ways to reduce the total cost of care while improving patient outcomes.
HFMA Comments on the CY 2019 OPPS/ASC Propsed Rule
HFMA submits comments to CMS on the CY 2019 hospital OPPS/ASC proposed rule, published in the July 31, 2018, Federal Register.
HFMA Comments on the CY 2019 Physician Fee Schedule Proposed Rule
HFMA submits comments to CMS on the CY 2019 Medicare Physician Fee Schedule Proposed Rule, published in the July 27, 2018, Federal Register.
HFMA Comments on FY2019 IPPS Proposed Rule
HFMA submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the FY2019 IPPS proposed rule published in the May 7, 2018, Federal Register.
HFMA Comments on the Senate Transparency Initiative
HFMA provides comments to Senators to inform the bipartisan initiative to increase healthcare price and quality transparency, as described in a February 28, 2018, letter.
HFMA Comments on the CY18 OPPS/ASC Proposed Rule
HFMA submitted comments to CMS on the CY 2018 OPPS/ASC proposed rule.
HFMA Comments on CY18 Physician Fee Schedule Proposed Rule
HFMA commented on CMS’s CY 2018 Physician Fee Schedule proposed rule.